11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →
Join Veristat at the DTRA 2022 Annual Meeting
Veristat will attend the DTRA 2022 Annual Meeting on the 6-9 November 2022 in Boston.
Decentralized Clinical Trials at Veristat
Veristat’s streamlined DCT deployment model significantly eases the burden on patients and sites through remote monitoring, patient reported outcomes, e-consent and at-home nursing. Additionally, Veristat has introduced our own virtual site inclusive of patient accrual, call-center intake and protocol visit completion.
If you would like to meet us at the DTRA Annual Meeting 2022 , feel free to contact us to arrange a meeting through the form.

11 min read
Oct 21, 2026 Veristat Blog
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...